Adjunct Therapy With All- trans -Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad460 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Baldeep Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India. Hauptthemen laut MEDLINE: Tretinoin, Mycobacterium tuberculosis, Tuberculosis, Antitubercular Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Department of Science and Technology, Government of India, International Centre for Genetic Engineering and Biotechnology.
Abstract (Originalsprache)
Tuberculosis is the second leading infectious killer after coronavirus disease 2019 (COVID-19). Standard antitubercular drugs exhibit various limitations like toxicity, long treatment regimens, and lack of effect against dormant and drug-resistant organisms. Here, we report that all-trans-retinoic acid (ATRA) improves Mycobacterium tuberculosis clearance in mice during treatment with the antitubercular drug isoniazid. Interestingly, ATRA promoted activities of lysosomes and mitochondria, and production of various inflammatory mediators in macrophages. Furthermore, ATRA upregulated the expression of genes of lipid metabolism pathways in macrophages. We demonstrated that ATRA activated the MEK/ERK pathway in macrophages in vitro and MEK/ERK and p38 MAPK pathways in mice. Finally, ATRA induced both Th1 and Th17 responses in lungs and spleens of M. tuberculosis-infected mice. Together, these data indicate that ATRA provides beneficial adjunct therapeutic value by modulating MEK/ERK and p38 MAPK pathways and thus warrants further testing for human use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
- Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
ORCID-Profile: Ved Prakash Dwivedi
Förderung
- Department of Science and Technology
- Government of India
- International Centre for Genetic Engineering and Biotechnology
Zitieren
APA
Singh, B., Pahuja, I., Yadav, P., Shaji, A., Chaturvedi, S., Ranganathan, A., Dwivedi, V. P., & Das, G. (2024). Adjunct Therapy With All- trans -Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad460
Vancouver
Singh B, Pahuja I, Yadav P, Shaji A, Chaturvedi S, Ranganathan A, et al. Adjunct Therapy With All- trans -Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad460
BibTeX
@article{Singh2024,
author = {Singh, Baldeep and Pahuja, Isha and Yadav, Priyanka and Shaji, Aishwarya and Chaturvedi, Shivam and Ranganathan, Anand and Dwivedi, Ved Prakash and Das, Gobardhan},
title = {Adjunct Therapy With All- trans -Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad460}
}
EUVIMED